Correction: Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy
Main Authors: | Jacqui T. Nimmo, Ajay Verma, Jean-Cosme Dodart, Chang Yi Wang, Jimmy Savistchenko, Ronald Melki, Roxana O. Carare, James A. R. Nicoll |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-01-01
|
Series: | Alzheimer’s Research & Therapy |
Online Access: | https://doi.org/10.1186/s13195-022-01156-8 |
Similar Items
-
AAV-mediated expression of a new conformational anti-aggregated α-synuclein antibody prolongs survival in a genetic model of α-synucleinopathies
by: Matthias Düchs, et al.
Published: (2023-06-01) -
Region-Specific Effects of Immunotherapy With Antibodies Targeting α-synuclein in a Transgenic Model of Synucleinopathy
by: Martin Kallab, et al.
Published: (2018-07-01) -
α-Synuclein pathology in post-mortem retina and optic nerve is specific for α-synucleinopathies
by: Frederique J. Hart de Ruyter, et al.
Published: (2023-08-01) -
The Interplay between α-Synuclein and Microglia in α-Synucleinopathies
by: Jacob S. Deyell, et al.
Published: (2023-01-01) -
Pathological α-synuclein detected by real-time quaking-induced conversion in synucleinopathies
by: Juan Huang, et al.
Published: (2024-03-01)